80 related articles for article (PubMed ID: 19958226)
1. Tamoxifen-2-hydroxylpropyl-beta-cyclodextrin-aggregated nanoassembly for nonbreast estrogen-receptor-positive cancer therapy.
Shukla J; Sharma U; Kar R; Varma IK; Juyal S; Jagannathan NR; Bandopadhyaya GP
Nanomedicine (Lond); 2009 Dec; 4(8):895-902. PubMed ID: 19958226
[TBL] [Abstract][Full Text] [Related]
2. Tamoxifen citrate loaded amphiphilic beta-cyclodextrin nanoparticles: in vitro characterization and cytotoxicity.
Memisoglu-Bilensoy E; Vural I; Bochot A; Renoir JM; Duchene D; Hincal AA
J Control Release; 2005 Jun; 104(3):489-96. PubMed ID: 15911048
[TBL] [Abstract][Full Text] [Related]
3. Rationale for sequential tamoxifen and anticancer drugs in adjuvant setting for patients with node- and receptor-positive breast cancer.
Kim R; Tanabe K; Emi M; Uchida Y; Osaki A; Toge T
Int J Oncol; 2005 Apr; 26(4):1025-31. PubMed ID: 15753998
[TBL] [Abstract][Full Text] [Related]
4. Keratinocyte growth factor (KGF) induces tamoxifen (Tam) resistance in human breast cancer MCF-7 cells.
Chang HL; Sugimoto Y; Liu S; Ye W; Wang LS; Huang YW; Lin YC
Anticancer Res; 2006; 26(3A):1773-84. PubMed ID: 16827106
[TBL] [Abstract][Full Text] [Related]
5. Tamoxifen lowers the MMP-9/TIMP-1 ratio and inhibits the invasion capacity of ER-positive non-small cell lung cancer cells.
Wang XY; Wang Y; Liu HC
Biomed Pharmacother; 2011 Oct; 65(7):525-8. PubMed ID: 21993004
[TBL] [Abstract][Full Text] [Related]
6. Photodynamic cell-kill analysis of breast tumor cells with a tamoxifen-pyropheophorbide conjugate.
Fernandez Gacio A; Fernandez-Marcos C; Swamy N; Dunn D; Ray R
J Cell Biochem; 2006 Oct; 99(3):665-70. PubMed ID: 16795032
[TBL] [Abstract][Full Text] [Related]
7. Effects of prolonged tamoxifen treatment on receptor expression and apoptosis of ovarian cancer cells.
Zhou R; Treeck O; Horn F; Ortmann O
Gynecol Oncol; 2005 Mar; 96(3):678-83. PubMed ID: 15721411
[TBL] [Abstract][Full Text] [Related]
8. Novel Tamoxifen Nanoformulations for Improving Breast Cancer Treatment: Old Wine in New Bottles.
Day CM; Hickey SM; Song Y; Plush SE; Garg S
Molecules; 2020 Mar; 25(5):. PubMed ID: 32151063
[TBL] [Abstract][Full Text] [Related]
9. Tamoxifen induces the expression of maspin through estrogen receptor-alpha.
Liu Z; Shi HY; Nawaz Z; Zhang M
Cancer Lett; 2004 Jun; 209(1):55-65. PubMed ID: 15145521
[TBL] [Abstract][Full Text] [Related]
10. [Cytotoxicity of tamoxifen and its principal metabolites in human breast cancer cell lines].
Bachmann-Moisson N; Barberi-Heyob M; Merlin JL; Ledrich ML; Batt AM; Guillemin F
Bull Cancer; 1996 Oct; 83(10):808-15. PubMed ID: 8952630
[TBL] [Abstract][Full Text] [Related]
11. Antitumor action of physiological estradiol on tamoxifen-stimulated breast tumors grown in athymic mice.
Yao K; Lee ES; Bentrem DJ; England G; Schafer JI; O'Regan RM; Jordan VC
Clin Cancer Res; 2000 May; 6(5):2028-36. PubMed ID: 10815929
[TBL] [Abstract][Full Text] [Related]
12. Tamoxifen derivatives for delivery of the antitumoral (DACH)Pt group: selective synthesis by McMurry coupling, and biochemical behaviour.
Top S; Kaloun el B; Vessières A; Leclercq G; Laïos I; Ourevitch M; Deuschel C; McGlinchey MJ; Jaouen G
Chembiochem; 2003 Aug; 4(8):754-61. PubMed ID: 12898627
[TBL] [Abstract][Full Text] [Related]
13. Complex formation of chlorhexidine gluconate with hydroxypropyl-β-cyclodextrin (HPβCD) by proton nuclear magnetic resonance spectroscopy ((1)H NMR).
Onnainty R; Longhi MR; Granero GE
Carbohydr Res; 2011 Jun; 346(8):1037-46. PubMed ID: 21489411
[TBL] [Abstract][Full Text] [Related]
14. Dietary flaxseed interaction with tamoxifen induced tumor regression in athymic mice with MCF-7 xenografts by downregulating the expression of estrogen related gene products and signal transduction pathways.
Chen J; Power KA; Mann J; Cheng A; Thompson LU
Nutr Cancer; 2007; 58(2):162-70. PubMed ID: 17640162
[TBL] [Abstract][Full Text] [Related]
15. Role of mitochondria in tamoxifen-induced rapid death of MCF-7 breast cancer cells.
Kallio A; Zheng A; Dahllund J; Heiskanen KM; Härkönen P
Apoptosis; 2005 Dec; 10(6):1395-410. PubMed ID: 16215679
[TBL] [Abstract][Full Text] [Related]
16. In vivo and in vitro demonstration of herb-drug interference in human breast cancer cells treated with tamoxifen and trastuzumab.
Chen JL; Wang JY; Tsai YF; Lin YH; Tseng LM; Chang WC; King KL; Chen WS; Chiu JH; Shyr YM
Menopause; 2013 Jun; 20(6):646-54. PubMed ID: 23340260
[TBL] [Abstract][Full Text] [Related]
17. Induction of p21WAF1 expression via Sp1-binding sites by tamoxifen in estrogen receptor-negative lung cancer cells.
Lee TH; Chuang LY; Hung WC
Oncogene; 2000 Aug; 19(33):3766-73. PubMed ID: 10949931
[TBL] [Abstract][Full Text] [Related]
18. Tamoxifen-induced antitumorigenic/antiestrogenic action synergized by a selective aryl hydrocarbon receptor modulator.
McDougal A; Wormke M; Calvin J; Safe S
Cancer Res; 2001 May; 61(10):3902-7. PubMed ID: 11358803
[TBL] [Abstract][Full Text] [Related]
19. beta-Sitosterol enhances tamoxifen effectiveness on breast cancer cells by affecting ceramide metabolism.
Awad AB; Barta SL; Fink CS; Bradford PG
Mol Nutr Food Res; 2008 Apr; 52(4):419-26. PubMed ID: 18338406
[TBL] [Abstract][Full Text] [Related]
20. A ferrocenyl derivative of hydroxytamoxifen elicits an estrogen receptor-independent mechanism of action in breast cancer cell lines.
Vessières A; Corbet C; Heldt JM; Lories N; Jouy N; Laïos I; Leclercq G; Jaouen G; Toillon RA
J Inorg Biochem; 2010 May; 104(5):503-11. PubMed ID: 20116857
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]